Jubilant Pharmo

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE700A01033
  • NSEID: JUBLPHARMA
  • BSEID: 530019
INR
960.00
28.25 (3.03%)
BSENSE

Aug 10

BSE+NSE Vol: 3.8 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
2,229.40
2,290.00
2,122.50
1,966.40
1,900.70
1,928.80
1,821.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,229.40
2,290.00
2,122.50
1,966.40
1,900.70
1,928.80
1,821.70
Raw Material Cost
638.30
642.80
592.10
564.90
520.50
584.00
467.00
Purchase of Finished goods
86.90
84.50
82.00
73.60
73.00
84.80
81.20
(Increase) / Decrease In Stocks
23.50
-14.00
42.20
-42.00
24.70
-42.70
26.20
Employee Cost
753.50
766.90
706.40
636.20
591.10
590.60
560.10
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
479.20
470.50
410.30
392.30
401.80
366.70
399.80
Total Expenditure (Excl Depreciation)
1,981.40
1,950.70
1,833.00
1,625.00
1,611.10
1,583.40
1,534.30
Operating Profit (PBDIT) excl Other Income
248.00
339.30
289.50
341.40
289.60
345.40
287.40
Other Income
19.90
23.70
20.50
9.80
12.00
11.90
9.20
Operating Profit (PBDIT)
267.90
363.00
310.00
351.20
301.60
357.30
296.60
Interest
54.20
56.50
56.10
50.20
49.00
52.70
55.60
Exceptional Items
0.00
-13.70
-39.70
-5.80
0.00
-3.30
-18.90
Gross Profit (PBDT)
213.70
292.80
214.20
295.20
252.60
301.30
222.10
Depreciation
127.30
116.80
120.70
104.80
98.10
95.20
91.30
Profit Before Tax
86.40
176.00
93.40
190.30
154.40
206.00
130.50
Tax
30.00
56.70
37.60
70.40
51.90
54.70
29.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
56.40
119.30
55.90
120.00
102.60
151.40
101.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
56.40
119.30
55.90
120.00
102.60
151.40
101.00
Share in Profit of Associates
0.00
0.00
-0.10
-0.10
-0.10
-0.10
-0.30
Minority Interest
-0.10
-0.10
-0.10
-0.40
-0.40
-2.30
-0.20
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
56.50
119.40
55.90
120.30
102.90
153.60
100.90
Equity Capital
15.80
15.80
15.80
15.80
15.80
15.80
15.80
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.58
7.56
3.54
7.61
6.51
9.72
6.39
Diluted Earnings per share
3.56
7.52
3.52
7.57
6.47
9.68
6.36
Operating Profit Margin (Excl OI)
11.17%
14.93%
13.68%
17.44%
15.41%
18.03%
15.85%
Gross Profit Margin
9.62%
12.89%
10.12%
15.08%
13.44%
15.73%
12.25%
PAT Margin
2.54%
5.25%
2.64%
6.12%
5.46%
7.9%
5.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 17.29% vs 9.76% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is -45.09% vs -78.66% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is -14.36% vs 15.15% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 10.61% vs -30.99% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of Jubilant Pharmo With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,229.40
0
2,229.40
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,229.40
0
2,229.40
Raw Material Cost
638.30
0
638.30
Purchase of Finished goods
86.90
0
86.90
(Increase) / Decrease In Stocks
23.50
0
23.50
Employee Cost
753.50
0
753.50
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
479.20
0.00
479.20
Total Expenditure (Excl Depreciation)
1,981.40
0
1,981.40
Operating Profit (PBDIT) excl Other Income
248.00
0.00
248.00
Other Income
19.90
0
19.90
Operating Profit (PBDIT)
267.90
0
267.90
Interest
54.20
0
54.20
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
213.70
0
213.70
Depreciation
127.30
0
127.30
Profit Before Tax
86.40
0
86.40
Tax
30.00
0
30.00
Provisions and contingencies
0.00
0
0.00
Profit After Tax
56.40
0
56.40
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
56.40
0
56.40
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.10
0
-0.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
56.50
0
56.50
Equity Capital
15.80
0
15.80
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
3.58
0
3.58
Diluted Earnings per share
3.56
0
3.56
Operating Profit Margin (Excl OI)
11.17%
0%
0.00
11.17%
Gross Profit Margin
9.62%
0%
0.00
9.62%
PAT Margin
2.54%
0%
0.00
2.54%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,229.40 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -2.65% vs 7.89% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 17.29% vs 9.76% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 56.50 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -52.68% vs 113.60% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -45.09% vs -78.66% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 248.00 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -26.91% vs 17.20% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -14.36% vs 15.15% in Jun 2025

Quarterly - Interest
Interest 54.20 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -4.07% vs 0.71% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 10.61% vs -30.99% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.17%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025